Tower Research Capital (TRC)’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-262
| Closed | -$87 | – | 6094 |
|
|
2024
Q2 | $87 | Sell |
262
-1,123
| -81% | -$303 | ﹤0.01% | 5502 |
|
|
2024
Q1 | $318 | Buy |
1,385
+1,123
| +429% | +$326 | ﹤0.01% | 5543 |
|
|
2023
Q4 | $84 | Sell |
262
-34,517
| -99% | -$8.9K | ﹤0.01% | 5727 |
|
|
2023
Q3 | $9.39K | Buy |
34,779
+34,517
| +13,174% | +$12.5K | ﹤0.01% | 4225 |
|
|
2023
Q2 | $132 | Hold |
262
| – | – | ﹤0.01% | 5785 |
|
|
2023
Q1 | $0 | Hold |
262
| – | – | ﹤0.01% | 6444 |
|
|
2022
Q4 | $0 | Hold |
262
| – | – | ﹤0.01% | 6533 |
|
|
2022
Q3 | $0 | Hold |
262
| – | – | ﹤0.01% | 6617 |
|
|
2022
Q2 | $0 | Sell |
262
-12,583
| -98% | -$5.62K | ﹤0.01% | 6665 |
|
|
2022
Q1 | $8K | Sell |
12,845
-3,402
| -21% | -$2.62K | ﹤0.01% | 4634 |
|
|
2021
Q4 | $18K | Sell |
16,247
-4,975
| -23% | -$7.69K | ﹤0.01% | 3814 |
|
|
2021
Q3 | $39K | Buy |
21,222
+13,873
| +189% | +$31.2K | ﹤0.01% | 3163 |
|
|
2021
Q2 | $23K | Buy |
+7,349
| New | +$18.4K | ﹤0.01% | 3774 |
|
|
2021
Q1 | – | Sell |
-9,285
| Closed | -$6K | – | 5810 |
|
|
2020
Q4 | $6K | Buy |
+9,285
| New | +$4.25K | ﹤0.01% | 4570 |
|
|
2020
Q3 | – | Sell |
-5,479
| Closed | -$3K | – | 5170 |
|
|
2020
Q2 | $3K | Buy |
+5,479
| New | +$2.64K | ﹤0.01% | 4442 |
|
|
2020
Q1 | – | Sell |
-3,014
| Closed | -$4K | – | 4092 |
|
|
2019
Q4 | $4K | Buy |
+3,014
| New | +$10.5K | ﹤0.01% | 2833 |
|
|
2019
Q2 | – | Sell |
-50
| Closed | -$2K | – | 4439 |
|
|
2019
Q1 | $2K | Buy |
50
+42
| +525% | +$1.41K | ﹤0.01% | 3481 |
|
|
2018
Q4 | $0 | Buy |
+8
| New | +$364 | ﹤0.01% | 4489 |
|
|
2018
Q1 | – | Sell |
-333
| Closed | -$8K | – | 3966 |
|
|
2017
Q4 | $8K | Buy |
+333
| New | +$10.2K | ﹤0.01% | 2694 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$2K | – | 3595 |
|
|
2017
Q1 | $2K | Sell |
100
-501
| -83% | -$8.68K | ﹤0.01% | 2685 |
|
|
2016
Q4 | $10K | Buy |
+601
| New | +$12.3K | ﹤0.01% | 2676 |
|
|
2016
Q3 | – | Sell |
-824
| Closed | -$13K | – | 4610 |
|
|
2016
Q2 | $13K | Buy |
824
+790
| +2,324% | +$24.8K | ﹤0.01% | 2615 |
|
|
2016
Q1 | $2K | Sell |
34
-460
| -93% | -$19.7K | ﹤0.01% | 3467 |
|
|
2015
Q4 | $16K | Buy |
494
+88
| +22% | +$2.83K | ﹤0.01% | 1556 |
|
|
2015
Q3 | $12K | Sell |
406
-69
| -15% | -$2.56K | ﹤0.01% | 2179 |
|
|
2015
Q2 | $18K | Buy |
475
+395
| +494% | +$18.2K | ﹤0.01% | 2203 |
|
|
2015
Q1 | $3K | Buy |
80
+39
| +95% | +$1.47K | ﹤0.01% | 3613 |
|
|
2014
Q4 | $2K | Sell |
41
-601
| -94% | -$24.8K | ﹤0.01% | 3412 |
|
|
2014
Q3 | $36K | Buy |
642
+601
| +1,466% | +$32.4K | ﹤0.01% | 1822 |
|
|
2014
Q2 | $3K | Buy |
+41
| New | +$2.37K | ﹤0.01% | 3252 |
|
Other funds holding ASXC
Tower Research Capital (TRC)'s ASXC Position: Q3 2024 in Review
Tower Research Capital (TRC) sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 262 shares — an estimated $87 sold.
Tower Research Capital (TRC) first reported a position in ASXC in Q2 2014 and held it in 30 quarters. The position peaked at $39K in Q3 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.
- Tower Research Capital (TRC) reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 262 Asensus Surgical, Inc. shares in Q3 2024, an estimated $87.
- Tower Research Capital (TRC) first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 30 quarters.
- Tower Research Capital (TRC)'s Asensus Surgical, Inc. position peaked at $39K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.